InsidersTradesSigma
Discover the complete record of transactions filed by GRAF FINCKENSTEIN FRIEDRICH, Directeur Médical. Officer active across 1 companies, notably Iovance Biotherapeutics, INC.. Aggregated, 1 disclosures have been published. The latest transaction was disclosed on 14 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Friedrich Graf Finckenstein serves as Chief Medical Officer at IOVANCE BIOTHERAPEUTICS, INC. In this role, he is responsible for overseeing the medical and clinical aspects of the company's operations. Friedrich brings his expertise to guide product development and ensure compliance with regulatory standards. His leadership is essential for innovation and continuous improvement in the healthcare solutions provided by the company.